Trade the Arkema share!

Analysis before buying or selling Arkema shares

Trade the Arkema share!

Your capital is at risk
Chart provided by Tradingview

The chemical industry is a highly sought after sector by investors in the stock markets that wish to invest in shares that are both liquid and volatile. In the European sector, in particular the French stock market, one particular company distinguishes itself; Arkema, we shall examine this company in detail in this article to assist you in completing comprehensive analyses of its share price.

Dividend payments
Can I receive dividends when I buy Arkema shares?
Information on Arkema shares
ISIN code: FR0010313833
Ticker: EPA: AKE
Index or market: Euronext Paris

How to buy and sell Arkema shares?

Open an account by clicking here
Deposit Funds
Search Arkema (EPA: AKE)
Buy/Sell Arkema shares
Your capital is at risk

Elements to consider before selling or buying Arkema shares

Analysis N°1

The activities of the Arkema Group remain very cyclical which represents a significant risk over the long term. The group’s activities are also sensitive to the exchange rate with the American dollar and the prices of commodities such as crude oil, electricity and also agricultural commodities.

Analysis N°2

We would of course monitor carefully the objectives fixed by the Arkema Group and its ambition to become the uncontested leader in the speciality chemicals and advanced materials sectors. The data you need to take into account primarily relate to sales, particularly in the emerging countries, as well as the operating margins and debt level. The growth of this company on the Asian market is also crucial for the group’s future and therefore we would monitor any financial benefits from new factories in its markets and the growth of sales in the markets of the countries that provide a strong return.

Analysis N°3

Of course, you will need to keep a watchful eye on all buyout operations as well as divestments or sales and their economical consequences as related to the objectives of the Arkema Company.

Analysis N°4

The Arkema Group continues unceasingly to announce its growth perspectives relating to operational profits and these objectives need to be verified against the actual results.

Analysis N°5

You then need to take into account the innovative capabilities of this company, notably in future areas of interest relating to green and renewable energy.

Analysis before buying or selling Arkema shares
Buy Arkema shares
Sell Arkema shares
Your capital is at risk

General presentation of Arkema

Buy Arkema shares

The Arkema Group is currently one of the international leaders in the production, development and sales of chemical products. However the chemical products concerned are from different sectors representing a varied clientele with mainly industrial chemical products but also high performance chemical products.

Arkema possesses over 90 production sites around the world and sells its products in France as well as other European countries, North America and also Asia.

Photo credits: ©piter2121/123RF.COM

The major competitors of Arkema

The Arkema Group is a specialist in the industrial chemical sector. It must therefore resist strong competition from other leading international companies in this activity sector. As a trader you need to know the major competitors to this company in order to integrate certain important data into your fundamental analyses. To best anticipate the future movements of this company’s share price on the stock markets you will need to take into account the respective results from each of Arkema’s major competitors as well as their market share and determine their influence on the perspectives and results of this group and its share price.

To assist you here is a list of the major competitors in the industrial chemicals sector that represent a threat to the Arkema Company:  

Dow Chemical

Mitsubishi chemical holdings

The major partners of Arkema

In 2007 the Paris stock market lauded a worldwide partnership agreement between Arkema and Spraying Systems for the technical development and marketing of coating solutions destined for returnable glass bottles.

Brewer Science

In 2015, Brewer Science and Arkema signed a partnership to develop high performance materials for the semi-conductor market.


In 2016 this company announced a renewal of its partnership with Arkema for 4 years and 42 million Euros. Through this agreement Suez became responsible for the management and valorisation of around 240,000 tons of waste at 28 Arkema sites in France.


In 2017 the consultancy and brokerage company ColisConsult responsible for transport implemented an alliance with the French chemistry company, Arkema. ColisConsult thereby became responsible for the shipment optimisation of around 100,000 packages per year on national and international levels completed from nearly 60 European sites of the Arkema Company divided among 16 countries.

Trade the Arkema share!
Your capital is at risk. Performance is not a guide to future performance and is not constant over time.
Positive factors for Arkema shares
The factors in favour of a rise in the Arkema share price:

Firstly, the Arkema Group offers an undeniable advantage concerning the organisation of its activities. In fact, this previous subsidiary of the Total Group is organised around three sectors of activities among which sales are fairly evenly divided. These are the high performance materials sector and those of specialty chemicals and paints.

Arkema is also well positioned on a worldwide level with the majority of its activities where it is currently the leader.

Recently the Arkema Group also decided to concentrate on its speciality chemicals activities as well as certain niche sectors such as renewable energy, water purification, lighter materials and plant chemistry which would enable the company to significantly reduce its cyclical bias.

For the investors, the relatively low level of debt compared to that of its competitors in this sector is also a considerable advantage.

We also note that one of the advantages of this company is the excellent division of its activities around the world. Although the European market is still in the lead with 40% of the company sales, the North American market and that of Asia still produce 34% and 20% respectively of the sales. The group essentially concentrates on the American and Chinese markets which are currently highly popular.

The Arkema Group also attracts by its capability to achieve targeted and high quality acquisitions that notably enable this company to diversify its activities and target new markets.

Finally, the long term objectives for the dividends remain bullish with an increase that is highly attractive for the shareholders.

Negative factors for Arkema shares
The factors in favour of a drop in the Arkema share price:

Firstly, the lack of visibility of this group relating to its worldwide economic growth could negatively influence the resumption of the Arkema Group’s activities which notably depend on industrial requirements.

Although this group has been trying to diversify through various niche activities as explained earlier, it unfortunately remains highly exposed to cyclical markets where it achieves over 50% of its sales. The acrylic paints market which generates over 15% of this company’s sales is notably suffering from a significant crisis with a significant drop in prices.

In the same way, the strong implications for the Arkema Company relating to the highly advantageous Chinese market could quickly and easily lead to a risk of overcapacity.

Of course, the Arkema group and its shares on the stock market are also sensitive to policy decisions notably those related to pollution which the company is wary of especially on the subject of a minimum carbon price.

Finally, the objectives of the group relating to its growth and announcements for 2020 are not unanimously accepted by the analysts that see them as too ambitious and unrealistic.

The information supplied here is only for indicative purposes and should not be used without the completion of a comprehensive and complete fundamental analysis of this asset notably taking into account exterior data, future publications and announcements and all fundamental events and news that could influence the strengths and weaknesses or make them more or less significant. This information does not in any way constitute recommendations relating to the completion of transactions or a solicitation to buy or sell an asset.

Frequently Asked Questions

What are the different subsidiaries owned by the Arkema group?

Arkema operates through a number of subsidiaries, including Ashland in adhesives, Bostik in bonding solutions, Coatex in rheology additives, PLPC International in carbon sulphide chemistry, Santomer in specialty acrylates for UV curing systems, Den Braven in high-performance sealants for insulation and Casda in sebacic acid from castor oil.

Who are the largest shareholders in Arkema?

Arkema's capital is partly free-floating and the other part is held by private shareholders including ISALT or Investissements Stratégiques en Actions Long Terme with 7.75%, Amundi Asset Management with 6.70%, Bpifrance Investissement with 6.12%, Norges Bank Investment Management with 5.65%, Nassef Sawiris with 5.40%, William Blair Investment Management with 2.73%, The Vanguard Group with 2.29%, Henderson Global Investors with 1.54% and BlackRock Investment Management with 1.49%.

Where and how to buy or sell Arkema shares?

To buy or sell Arkema shares online, you can go through a securities account and place a stock market order on an online broker's platform. This will allow you to hold these shares. But you can also speculate on the share price with a derivative product such as CFDs or contracts for difference offered by online brokers.

Trade the Arkema share!

eToro is a multi-asset platform which offers both investing in stocks and cryptoassets, as well as trading CFDs.

Please note that CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. {etoroCFDrisk}% of retail CFD accounts lose money. You should consider whether you can afford to take the high risk of losing your money.

Past performance is not an indication of future results. Trading history presented is less than 5 complete years and may not suffice as basis for investment decision.

Copy trading is a portfolio management service, provided by eToro (Europe) Ltd., which is authorised and regulated by the Cyprus Securities and Exchange Commission.

Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.

eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro.